GLP-1 drugs like Ozempic and Zepbound are some of the biggest blockbusters in pharmaceutical history.
The overdose epidemic is one of the biggest public health crises in the U.S.
What if drugs like Ozempic could be used to treat addiction? There’s actually some reason to believe they could be.
In this episode of STATus Report, host Alex Hogan takes a look at the state of this research, and talks to addiction reporter Lev Facher and physician Steven Klein, who is already prescribing GLP-1s to his addiction patients. Facher recently visited the treatment center where Klein is a staff physician and wrote about it for STAT.
